Editas Medicine Competitors and Similar CompaniesClear all
Editas Medicine's competitors and similar companies include Biocytogen Boston, Amyris, Caribou Biosciences and Nuclera.
 Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. |  Amyris Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation. |  Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | |||
Founding Date | Founding Date 2013 | Founding Date 2008 | Founding Date 2003 | Founding Date 2012 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Waltham, US HQ Beijing, CN Nantong, CN Shanghai, CN Heidelberg, DE San Diego, US San Francisco, US | Locations Emeryville, US HQ Sao Paulo, BR | Locations Berkeley, US HQ | Locations Cambridge, GB HQ |
Employees | Employees 20816% increase | Employees 1833% increase | Employees 1,0031% decrease | Employees 1477% decrease | Employees 1192% decrease |
Valuation ($) | Valuation ($) 256.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 174.4 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $40.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $269.8m (FY, 2022) | Revenue (est.) $11.2m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($160.1m) (FY, 2025) | Net income N/A | Net income ($543.4m) (FY, 2022) | Net income ($148.1m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 34m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 10m (over 7 years ago) |
Total funding raised | Total funding raised $ 210m | Total funding raised $ 284.3m | Total funding raised $ 551.9m | Total funding raised $ 159.5m | Total funding raised $ 11.3m |
For sources of this data, please see the company profile
View Company Profiles
Biocytogen Boston
HQ
Waltham, US
Biocytogen Boston is a company that provides antibody drug development solutions.
View companyAmyris
HQ
Emeryville, US
Employees
1,003↓ 1% decrease
Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation.
View companyCaribou Biosciences
HQ
Berkeley, US
Employees
147↓ 7% decrease
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
View company
Nuclera
HQ
Cambridge, GB
Employees
119↓ 2% decrease
Nuclera is a company that specializes in DNA synthesis.
View company